Heterotopic Ossification and Related Conditions
Heterotopic Ossification and Related Conditions is a research topic within Rheumatology. Science Explorer counts 6.9k research works in it since 1950. 12.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the topic of heterotopic ossification, particularly in the context of fibrodysplasia ossificans progressiva (FOP). It covers various aspects including the role of BMP type I receptor mutations, progenitor cells, pathophysiology, prevention strategies, and the impact of traumatic injuries. Additionally, it explores the use of radiation therapy as a prophylactic measure.
- Heterotopic Ossification
- Fibrodysplasia Ossificans Progressiva
- BMP Type I Receptor
- ACVR1 Mutation
- Progenitor Cells
- Inhibition
- Pathophysiology
- Prevention
- Traumatic Injury
- Radiation Therapy
- Research works
- 6.9k fractional, since 1950
- In the world top 10%
- 856 per year above
- Top-10% rate
- 12.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +20% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Heterotopic Ossification and Related Conditions research?
By volume, the United States and China publish the most (268 and 208 works in 2022–2025).
By volume, 2022–2025
- 1 United States 268 works
- 2 China 208 works
- 3 India 89 works
- 4 Japan 78 works
- 5 United Kingdom 47 works
- 6 Germany 47 works
- 7 Italy 36 works
- 8 France 33 works
- 9 Spain 31 works
- 10 South Korea 30 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Heterotopic Ossification and Related Conditions research?
By volume in 2022–2025, Peking University publishes the most Heterotopic Ossification and Related Conditions research, followed by University of Pennsylvania and The University of Texas Southwestern Medical Center.
By volume, 2022–2025
- 1 Peking UniversityChina 6 works
- 2 University of PennsylvaniaUnited States 6 works
- 3 The University of Texas Southwestern Medical CenterUnited States 5 works
- 4 Sichuan UniversityChina 5 works
- 5 Mohammed V UniversityMorocco 5 works
- 6 University of MichiganUnited States 4 works
- 7 Post Graduate Institute of Medical Education and ResearchIndia 4 works
- 8 Mayo Clinic in ArizonaUnited States 4 works
- 9 West China Hospital of Sichuan UniversityChina 4 works
- 10 Shanghai Sixth People's HospitalChina 4 works
Where is Heterotopic Ossification and Related Conditions research done?
The largest centres of Heterotopic Ossification and Related Conditions research in 2022–2025 are Beijing (China), Shanghai (China), Tokyo (Japan) and London (United Kingdom).
Largest cities, 2022–2025
Is Heterotopic Ossification and Related Conditions research growing?
Output in 2018–2022 was 20% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Heterotopic Ossification and Related Conditions.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.